BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12080044)

  • 1. The promyelocytic leukemia protein represses A20-mediated transcription.
    Wu WS; Xu ZX; Chang KS
    J Biol Chem; 2002 Aug; 277(35):31734-9. PubMed ID: 12080044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B.
    Laherty CD; Perkins ND; Dixit VM
    J Biol Chem; 1993 Mar; 268(7):5032-9. PubMed ID: 8444879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
    Wu WS; Xu ZX; Hittelman WN; Salomoni P; Pandolfi PP; Chang KS
    J Biol Chem; 2003 Apr; 278(14):12294-304. PubMed ID: 12540841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements.
    Krikos A; Laherty CD; Dixit VM
    J Biol Chem; 1992 Sep; 267(25):17971-6. PubMed ID: 1381359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20 zinc finger protein inhibits TNF and IL-1 signaling.
    Jäättelä M; Mouritzen H; Elling F; Bastholm L
    J Immunol; 1996 Feb; 156(3):1166-73. PubMed ID: 8557994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.
    Kakizuka A; Miller WH; Umesono K; Warrell RP; Frankel SR; Murty VV; Dmitrovsky E; Evans RM
    Cell; 1991 Aug; 66(4):663-74. PubMed ID: 1652368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
    Wu WS; Xu ZX; Ran R; Meng F; Chang KS
    Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome.
    Zetoune FS; Murthy AR; Shao Z; Hlaing T; Zeidler MG; Li Y; Vincenz C
    Cytokine; 2001 Sep; 15(6):282-98. PubMed ID: 11594795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
    Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
    Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.
    Song HY; Rothe M; Goeddel DV
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6721-5. PubMed ID: 8692885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression.
    Xu ZX; Zhao RX; Ding T; Tran TT; Zhang W; Pandolfi PP; Chang KS
    J Biol Chem; 2004 Jan; 279(3):1838-44. PubMed ID: 14597622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interactions between the Epstein-Barr virus BZLF1 protein and the promyelocytic leukemia protein.
    Bowling BL; Adamson AL
    Virus Res; 2006 May; 117(2):244-53. PubMed ID: 16307818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.
    de Thé H; Lavau C; Marchio A; Chomienne C; Degos L; Dejean A
    Cell; 1991 Aug; 66(4):675-84. PubMed ID: 1652369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetics of acute promyelocytic leukemia.
    Grignani F; Fagioli M; Ferrucci PF; Alcalay M; Pelicci PG
    Blood Rev; 1993 Jun; 7(2):87-93. PubMed ID: 8396481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.